3 Biotechs That Might Get Bought Out in 2023

3 Biotechs That Might Get Bought Out in 2023

Source: 
Motley Fool
snippet: 

  • With multiple blockbuster drugs going off patent this decade, pharma companies are expected to ratchet up their M&A activities.
  • These three companies sport high-value assets that could attract suitors soon.